Mdr Gene Therapy for Drug Resistance in Breast Cancer


NIH 1998 U01 CA	Mdr Gene Therapy for Drug Resistance in Breast Cancer Antman, Karen / Columbia University (N.Y.)
NIH 1998 U01 CA	Mdr Gene Therapy for Drug Resistance in Breast Cancer Clinical Trials Antman, Karen / Columbia University (N.Y.)
NIH 1998 U01 CA	Development of Optimal Mdr Retroviral Vectors for Bone Marrow Gene Therapy Bank, Arthur / Columbia University (N.Y.)
NIH 1997 U01 CA	Mdr Gene Therapy for Drug Resistance in Breast Cancer Antman, Karen / Columbia University (N.Y.)
NIH 1997 U01 CA	Mdr Gene Therapy for Drug Resistance in Breast Cancer Clinical Trials Antman, Karen / Columbia University (N.Y.)
NIH 1997 U01 CA	Development of Optimal Mdr Retroviral Vectors for Bone Marrow Gene Therapy Bank, Arthur / Columbia University (N.Y.)
NIH 1996 U01 CA	Mdr Gene Therapy for Drug Resistance in Breast Cancer Antman, Karen / Columbia University (N.Y.)
NIH 1996 U01 CA	Mdr Gene Therapy for Drug Resistance in Breast Cancer Clinical Trials Antman, Karen /
NIH 1996 U01 CA	Development of Optimal Mdr Retroviral Vectors for Bone Marrow Gene Therapy Bank, Arthur /
NIH 1995 U01 CA	Mdr Gene Therapy for Drug Resistance in Breast Cancer Antman, Karen / Columbia University (N.Y.)

Bradley, M Brigid; Sattler, Rose M; Raftopoulos, Harry et al. (2002) Correction of phenotype in a thalassemia mouse model using a nonmyeloablative marrow transplantation regimen. Biol Blood Marrow Transplant 8:453-61

Lopez, Rocio A; Schoetz, Stuti; DeAngelis, Kathryn et al. (2002) Multiple hematopoietic defects and delayed globin switching in Ikaros null mice. Proc Natl Acad Sci U S A 99:602-7